Advertisement

Lung Tumors pp 163-166 | Cite as

Prognosis and End Results

  • S. G. Spiro
Part of the UICC Current Treatment of Cancer book series (1360)

Abstract

As detailed previously surgery offers the only major prospect of cure in non-small cell lung cancer. Of all patients presenting with this disease only 25% undergo thoracotomy following staging and, on average, about 5% of these subjects will still be unresectable despite a negative mediastinoscopy. This is almost always due to nodal involvement beyond the range of the mediastinoscope or tumor invading vital structures in the mediastinum. Thus about 20% of all patients will undergo a curative resection of which 4%–5% will be alive and tumor free at 5 years — a 25% 5-year survival rate overall for this selected group of resected patients (Fig.l). The other 15% of patients will die of local or distant recurrence within 5 years. The overall 5-year survival figure of 20%–30% and 10-year survival of 16%–18% (there is a significant falloff between 5 and 10 years due to metastatic spread from slowly growing lung cancers) has not changed during the last 30 years. These figures can, however, be somewhat misleading as they include 40%–50% of patients with stage I disease. In stage I disease the 2-year survival when staging was originally looked at by Mountain et al. in 1974 was 47% for squamous cell carcinoma (see Table 1).

Keywords

Lung Cancer Squamous Cell Carcinoma Small Cell Lung Cancer Distant Recurrence Inoperable Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  1. Huhti E, Sutinen S, Saloheimo M (1981) Survival among patients with lung cancer: an epidemio-logical study. Am Rev Respir Dis 124: 13–16PubMedGoogle Scholar
  2. Hyde L, Yee J, Wilson R, Patno ME (1965) Cell type and the natural history of lung cancer. JAMA 193: 52PubMedCrossRefGoogle Scholar
  3. Martini N, Beatie EJ (1977) Results of surgical treatment in stage I lung cancer. J Thorac Cardio-vasc Surg 74: 499–507Google Scholar
  4. Mountain CR (1977) Assessment of the role of surgery for control of lung cancer. Am Thorax Surg 24: 365–373CrossRefGoogle Scholar
  5. Mountain CF, Carr DT, Anderson WAD (1974) A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med 120: 130–138PubMedGoogle Scholar
  6. Roswitt B, Patno ME, Rapp R, Veinburgs A, Feder B, Stuhlbarg J, Reid CB (1968) The survival of patients with inoperable lung cancer: a large scale randomized study of radiation therapy versus placebo. Radiology 90: 688–697Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • S. G. Spiro

There are no affiliations available

Personalised recommendations